Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.

about

Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study.

P2860

Q38622569-EEF4AE0F-7BB5-42DA-8C0C-085ED487006A

P2860

Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.

Item

http://www.wikidata.org/entity/Q38925870

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Major Postoperative Complicati ...... ired Survival after CRS/HIPEC.

@en

type

Item

label

Major Postoperative Complicati ...... ired Survival after CRS/HIPEC.

@en

prefLabel

Major Postoperative Complicati ...... ired Survival after CRS/HIPEC.

@en

P1476

Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC

@en

P2093

Dilmurodjon Eshmuminov

http://www.w3.org/2001/XMLSchema#string

Marcel André Schneider

http://www.w3.org/2001/XMLSchema#string

P2860

Current views on the mechanisms of immune responses to trauma and infection

Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia.

Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.

P2888

s10434-017-5821-7

P304

2224-2232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-5821-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kuno Lehmann

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084256621

http://www.w3.org/2001/XMLSchema#string

P698

28265776

http://www.w3.org/2001/XMLSchema#string

Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.

about

P2860

P2860

Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698